RemeGen Co., Ltd.
REGMF · OTC
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Revenue | $2 | $1 | $1 | $1 |
| % Growth | 58.9% | 40.2% | -46.1% | – |
| Cost of Goods Sold | $0 | $0 | $0 | $0 |
| Gross Profit | $1 | $1 | $0 | $1 |
| % Margin | 80% | 76.5% | 64.8% | 95.3% |
| R&D Expenses | $2 | $1 | $1 | $1 |
| G&A Expenses | $0 | $0 | $0 | $0 |
| SG&A Expenses | $1 | $1 | $1 | $0 |
| Sales & Mktg Exp. | $1 | $1 | $0 | $0 |
| Other Operating Expenses | -$0 | -$0 | -$0 | $0 |
| Operating Expenses | $3 | $2 | $2 | $1 |
| Operating Income | -$1 | -$2 | -$1 | $0 |
| % Margin | -80.2% | -139.6% | -137.3% | 11.4% |
| Other Income/Exp. Net | -$0 | -$0 | $0 | $0 |
| Pre-Tax Income | -$1 | -$2 | -$1 | $0 |
| Tax Expense | $0 | $0 | $0 | $0 |
| Net Income | -$1 | -$2 | -$1 | $0 |
| % Margin | -85.9% | -140.4% | -130.1% | 19.4% |
| EPS | -2.73 | -2.8 | -1.88 | 0.57 |
| % Growth | 2.5% | -48.9% | -429.8% | – |
| EPS Diluted | -2.73 | -2.8 | -1.88 | 0.57 |
| Weighted Avg Shares Out | 1 | 1 | 1 | 0 |
| Weighted Avg Shares Out Dil | 1 | 1 | 1 | 0 |
| Supplemental Information | – | – | – | – |
| Interest Income | $0 | $0 | $0 | $0 |
| Interest Expense | $0 | $0 | $0 | $0 |
| Depreciation & Amortization | $0 | $0 | $0 | $0 |
| EBITDA | -$1 | -$1 | -$1 | $0 |
| % Margin | -64.1% | -116% | -104.9% | 28.2% |